BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14692977)

  • 21. Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis.
    Keklik M; Korkmaz S; Kalan U; Sarikoc M; Keklik E
    Transfus Apher Sci; 2016 Oct; 55(2):240-242. PubMed ID: 27522105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized crossover trial comparing three plateletpheresis machines.
    Bueno JL; García F; Castro E; Barea L; González R
    Transfusion; 2005 Aug; 45(8):1373-81. PubMed ID: 16078928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of concurrent collection of in-line filtered platelets and packed red blood cells by multicomponent apheresis with three last-generation apparatuses.
    Picker SM; Radojska SM; Gathof BS
    Vox Sang; 2006 Jul; 91(1):47-55. PubMed ID: 16756601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double red blood cell collection: comparison of three apheresis systems.
    Burgstaler EA; Duffy KJ; Gandhi MJ
    Transfusion; 2016 Sep; 56(9):2362-7. PubMed ID: 27409536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of quality assurance in plateletpheresis.
    Moog R; Müller N
    Transfus Sci; 1999 Oct; 21(2):141-5. PubMed ID: 10747522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood component collection by apheresis.
    Burgstaler EA
    J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
    Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
    J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plateletpheresis efficiency and mathematical correction of software-derived platelet yield prediction: A linear regression and ROC modeling approach.
    Jaime-Pérez JC; Jiménez-Castillo RA; Vázquez-Hernández KE; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
    J Clin Apher; 2017 Oct; 32(5):329-334. PubMed ID: 27862253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; Bunkens H; Eckstein R
    Transfusion; 2001 Mar; 41(3):396-400. PubMed ID: 11274597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular contamination of plasma collected with various apheresis systems.
    Valbonesi M; Bruni R; Florio G; Zanella A; Bunkens H
    Transfus Apher Sci; 2001 Feb; 24(1):91-4. PubMed ID: 11515618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; van Waeg G; Eckstein R
    Transfusion; 1997 Oct; 37(10):1045-9. PubMed ID: 9354823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.
    Alberts M; Bandarenko N; Gaca J; Lockhart E; Milano C; Alexander S; Linder D; Lombard FW; Welsby IJ
    Transfusion; 2014 May; 54(5):1348-57. PubMed ID: 24898456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.
    Kishimoto M; Ohto H; Shikama Y; Kikuta A; Kimijima I; Takenoshita S
    Transfusion; 2002 Oct; 42(10):1340-7. PubMed ID: 12423519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products.
    Santana JM; Dumont LJ
    Transfusion; 2006 Jun; 46(6):966-72. PubMed ID: 16734813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
    Wagner SJ; Seetharaman S; Kurtz J
    Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.